
Dr. Carla Greenbaum Talks about T1D TrialNet During the COVID-19 Pandemic
Carla Greenbaum, M.D., chair of TrialNet—an international Breakthrough T1D-supported network that is dedicated to finding cures for type 1 diabetes (T1D)—and a professor at Benaroya Research Institute, discussed T1D research in the time of COVID-19, including what TrialNet is up to, on Breakthrough T1D’s Facebook Live event. She chats about: What do we know now […]

5 Key Points from Q&A with Aaron Kowalski and Rob Howe
Included: navigating the fundraising challenges brought by COVID-19, how Breakthrough T1D has evolved as an organization, life with T1D in the 1970s and 1980s, the crucial role of advocacy, and the importance of the T1D community working together.

Breakthrough T1D Plays a Leadership Role, Again, to Marshal Resources for T1D Research
It’s 2004. The California Institute for Regenerative Medicine (CIRM), which will fund $3 billion in stem cell research to advances new therapies, is on the ballot, if it gets approved. Fortunately, the patients, families and scientists were the voices that day, with nearly 60% voting to approve it. In the time since 2004, it has […]

The Breakthrough T1D Journey: Where It All Began
Fifty years ago, two mothers came together to make the world a better place for their children and for other people burdened with type 1 diabetes.

How Much Exercise to Help Manage T1D and Optimize One’s Immune System?
Also, what it means to be “actively lazy”— and how to avoid it. And no gym, no home exercise equipment? Workarounds you can use to work out at home.

At the Front Lines in COVID-19: Breakthrough T1D-Funded Scientist’s Company Developing a Vaccine
With coronavirus closing schools and forcing so many people to stay inside or wear facemasks every time they step outdoors, COVID-19 is threatening to make everyone stir-crazy well into summer. And unfortunately, the safety of herd immunity remains a long way off. In the meantime, scientists are battling coronavirus in a number of ways, and […]

65+ Years Old and T1D: What “Higher Risk” Means and What You Should Do
How to protect yourself according to advice from type 1 diabetes medical experts and the CDC's recommendations for those at higher risk of severe illness.

Europe Supports Autoantibodies as Biomarkers for T1D
It was 2015—five years ago—that three organizations (BreakthroughT1D, the Endocrine Society and the American Diabetes Association) published a statement urging the adoption of a staging system of type 1 diabetes (T1D) that uses islet autoantibodies as biomarkers. (Biomarkers, in this sense, are indicators that a person is developing T1D but is still without symptoms.) It […]

JDRF-Beyond Type 1 Alliance Announce Global Covid-19 Prevention Guidance Campaign
The Breakthrough T1D-Beyond Type 1 Alliance has brought together leaders of the international diabetes community to create recommendations to curb the spread of Covid-19 and keep people with diabetes as safe as possible during the global pandemic.

Enhanced Charitable Giving Incentives Explained: What it Means for Donors in 2020
What the federal economic relief package, also known as the CARES Act (Coronavirus Aid, Relief, and Economic Security) means for donors to Breakthrough T1D.